Indications and uses
To be used for acute, self-limiting conditions according to standard homeopathic indications
To be used for acute, self-limiting conditions according to standard homeopathic indications
Take at onset of symptoms. Repeat every 2 hours or as needed until relieved. If conditions persists or worsens discontinue use and consult a practitioner. Adults: dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth Children and Infants: 1-5 pellets
Adults: dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth
Children and Infants: 1-5 pellets
To be used for acute, self-limiting conditions according to standard homeopathic indications
Lactose
Artemisia Abrotanum
Keep out of the reach of children
To be used for acute, self-limiting conditions according to standard homeopathic indications such as Indigestion
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 82797-333-10 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8926-d83d-e063-dadaa90ab31f | Masood Abrotanum |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82797-333-10 | Masood Abrotanum | 30 g in 1 BOTTLE, GLASS | PELLET | 30 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 82797-333 | 82797-333-10 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ARTEMISIA ABROTANUM FLOWERING TOP | QG07G580U0 | ACTIB |
| LACTOSE, UNSPECIFIED FORM | J2B2A4N98G | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f2e83031-7c38-784a-e053-2a95a90aa644 | f2e83031-7c37-784a-e053-2a95a90aa644 | 2023-01-22 | Warnings | f2e83031-7c38-784a-e053-2a95a90aa644 f2e83031-7c37-784a-e053-2a95a90aa644 |
Adverse event summaries are temporarily unavailable. Other product information remains available.